SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Blennow Kaj 1958 ) "

Sökning: WFRF:(Blennow Kaj 1958 )

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Rüetschi, Ulla, 1962-, et al. (författare)
  • Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
  • 2005
  • Ingår i: Experimental neurology. - 0014-4886. ; 196:2, s. 273-81
  • Tidskriftsartikel (refereegranskat)abstract
    • This investigation describes the discovery of novel possible cerebrospinal fluid (CSF) biomarkers for frontotemporal dementia (FTD) using surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS). Sixteen clinically diagnosed FTD patients and 12 non-demented controls were included in the study. CSF was collected and analyzed for protein expression by SELDI-TOF MS. The samples were analyzed on four different array surfaces using two different energy-absorbing molecules as matrices. In total each sample was subjected to eight different surface/matrix conditions. About 2000 protein peaks (mass/charge ratios) were detected. Forty-two peaks were differentially expressed in FTD (P < 0.01). After exclusion of peaks with low signal-to-noise ratio and/or poor resolution and peaks representing differentially charged proteins, 10 peaks remained, five of which were increased and five decreased in FTD cases compared to controls. Using partial least square discriminant analysis (PLS-DA), the combination of these biomarkers discriminated FTD from non-demented controls with a sensitivity of 94%, a specificity of 83% and an accuracy of 89%. Five of the peaks were purified further and identified by tandem MS as a fragment of neurosecretory protein VGF, transthyretin, S-cysteinylated transthyretin, truncated cystatin C and a fragment of chromogranin B. With use of these potential biomarkers, FTD can be distinguished from control subjects with high accuracy in this pilot study.
  •  
3.
  • Abramsson, Alexandra, 1973-, et al. (författare)
  • Proteomics Profiling of Single Organs from Individual Adult Zebrafish.
  • 2010
  • Ingår i: Zebrafish. - 1557-8542. ; 7:2, s. 161-168
  • Tidskriftsartikel (refereegranskat)abstract
    • Abstract The model organism zebrafish (Danio rerio) is extensively utilized in studies of developmental biology but is also being investigated in the context of a growing list of human age-related diseases. To facilitate such studies, we here present protein expression patterns of adult zebrafish organs, including blood, brain, fin, heart, intestine, liver, and skeletal muscle. Protein extracts were prepared from the different organs of two zebrafish and analyzed using liquid chromatography coupled to high-resolution tandem mass spectrometry. Zebrafish tissue was digested directly after minimal fractionation and cleaned up (the shotgun approach). Proteins were identified using Mascot software. In total, 1394 proteins were identified of which 644 were nonredundant. Of these, 373 demonstrated an organ-specific expression pattern and 57 had not been shown on protein level before. These data emphasize the need for increased research at the protein level to facilitate the selection of candidate proteins for targeted quantification and to refine systematic genetic network analysis in vertebrate development, biology, and disease.
  •  
4.
  •  
5.
  •  
6.
  • Alves, G., et al. (författare)
  • CSF A beta(42) predicts early-onset dementia in Parkinson disease
  • 2014
  • Ingår i: Neurology. - 0028-3878. ; 82:20, s. 1784-1790
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective:To test in vivo the proposal from clinicopathologic studies that -amyloid (A) pathology shortens the time to dementia in Parkinson disease (PD), and to explore the utility of CSF A and related measures as early prognostic biomarkers of dementia in an incident PD cohort.Methods:We assessed a population-based incident cohort of 104 patients with PD who underwent lumbar puncture at diagnosis. We analyzed CSF concentrations of A42, A40, and A38 using a multiplexed immunoassay with electrochemiluminescence (ECL) detection and levels of A42, total tau, and phosphorylated tau using ELISA. Patients were followed prospectively for 5 years. Dementia was diagnosed according to published criteria.Results:CSF levels of A42 were significantly decreased in patients who developed dementia (n = 20, 19.2%) compared to those who did not (n = 84, 80.8%), as measured by ECL (-33%, p = 0.006) as well as ELISA (-36%, p < 0.001). No differences were observed for other markers. Low A42 values predicted a substantially increased risk for subsequent dementia at high sensitivity (85%), with hazard ratios of 9.9 (95% confidence interval 2.3-43.5, p = 0.002) for A42(ECL) <376 pg/mL and 7.6 (2.2-26.4, p = 0.001) for A42(ELISA) <443 pg/mL, after adjustment for baseline age and PD-mild cognitive impairment (MCI) status. A42 reductions tended to precede the onset of PD-MCI that progressed to dementia.Conclusions:These in vivo data support the role of A pathology in the etiology and highlight the potential utility of CSF A42 as an early prognostic biomarker of dementia associated with PD.
  •  
7.
  • Alves, Guido, et al. (författare)
  • CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study.
  • 2010
  • Ingår i: Journal of neurology, neurosurgery, and psychiatry. - 1468-330X.
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Alzheimer's disease (AD) pathology is found in a considerable portion of patients with Parkinson's disease (PD), particularly those with early dementia (PDD). Altered cerebrospinal fluid (CSF) levels of amyloid-beta (Abeta) and tau proteins have been found in PDD, with intermediate changes for Abeta42 in non-demented PD. The authors investigated whether AD-related CSF protein levels are altered and relate to neuropsychological performance in early, untreated PD. Methods CSF concentrations of Abeta42, Abeta40 and Abeta38 were measured by electrochemiluminiscene and levels of total tau (T-tau) and phosphorylated tau (P-tau) by ELISA in 109 newly diagnosed, unmedicated, non-demented, community-based PD patients who had undergone comprehensive neuropsychological testing, and were compared with those of 36 age-matched normal controls and 20 subjects with mild AD. Results PD patients displayed significant reductions in Abeta42 (19%; p=0.009), Abeta40 (15.5%; p=0.008) and Abeta38 (23%; p=0.004) but not T-tau (p=0.816) or P-tau (p=0.531) compared with controls. CSF Abeta42 reductions in PD were less marked than in AD (53%; p=0.002). Sequential regression analyses demonstrated significant associations between CSF levels of Abeta42 (beta=0.205; p=0.019), Abeta40 (beta=0.378; p<0.001) and Abeta38 (beta=0.288; p=0.001) and memory impairment, but not executive-attentional or visuospatial dysfunction. Tau protein levels did not correlate with cognitive measures. Conclusion CSF Abeta levels are altered in a subset of patients with early PD and relate to memory impairment. Our study suggests that alterations in Abeta protein metabolism may contribute to the heterogeneity in pattern and course of cognitive decline associated with PD. Longitudinal studies are needed to clarify the clinical significance of CSF Abeta peptides as prognostic biomarkers in PD.
  •  
8.
  • Alves, Guido, et al. (författare)
  • CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
  • 2010
  • Ingår i: Journal of neurology, neurosurgery, and psychiatry. - 1468-330X. ; 81:10, s. 1080-1086
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Alzheimer's disease (AD) pathology is found in a considerable portion of patients with Parkinson's disease (PD), particularly those with early dementia (PDD). Altered cerebrospinal fluid (CSF) levels of amyloid-beta (Abeta) and tau proteins have been found in PDD, with intermediate changes for Abeta42 in non-demented PD. The authors investigated whether AD-related CSF protein levels are altered and relate to neuropsychological performance in early, untreated PD. Methods CSF concentrations of Abeta42, Abeta40 and Abeta38 were measured by electrochemiluminiscene and levels of total tau (T-tau) and phosphorylated tau (P-tau) by ELISA in 109 newly diagnosed, unmedicated, non-demented, community-based PD patients who had undergone comprehensive neuropsychological testing, and were compared with those of 36 age-matched normal controls and 20 subjects with mild AD. Results PD patients displayed significant reductions in Abeta42 (19%; p=0.009), Abeta40 (15.5%; p=0.008) and Abeta38 (23%; p=0.004) but not T-tau (p=0.816) or P-tau (p=0.531) compared with controls. CSF Abeta42 reductions in PD were less marked than in AD (53%; p=0.002). Sequential regression analyses demonstrated significant associations between CSF levels of Abeta42 (beta=0.205; p=0.019), Abeta40 (beta=0.378; p<0.001) and Abeta38 (beta=0.288; p=0.001) and memory impairment, but not executive-attentional or visuospatial dysfunction. Tau protein levels did not correlate with cognitive measures. Conclusion CSF Abeta levels are altered in a subset of patients with early PD and relate to memory impairment. Our study suggests that alterations in Abeta protein metabolism may contribute to the heterogeneity in pattern and course of cognitive decline associated with PD. Longitudinal studies are needed to clarify the clinical significance of CSF Abeta peptides as prognostic biomarkers in PD.
  •  
9.
  • Alves, Guido, et al. (författare)
  • CSF Aβ42 predicts early-onset dementia in Parkinson disease.
  • 2014
  • Ingår i: Neurology. - 1526-632X. ; 82:20, s. 1784-90
  • Tidskriftsartikel (refereegranskat)abstract
    • To test in vivo the proposal from clinicopathologic studies that β-amyloid (Aβ) pathology shortens the time to dementia in Parkinson disease (PD), and to explore the utility of CSF Aβ and related measures as early prognostic biomarkers of dementia in an incident PD cohort.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (21)
Typ av publikation
tidskriftsartikel (426)
forskningsöversikt (51)
konferensbidrag (16)
bok (6)
bokkapitel (4)
samlingsverk (redaktörskap) (1)
visa fler...
annan publikation (1)
visa färre...
Typ av innehåll
refereegranskat (473)
övrigt vetenskapligt (27)
populärvet., debatt m.m. (5)
Författare/redaktör
Blennow, Kaj, 1958-, (503)
Zetterberg, Henrik, ... (321)
Wallin, Anders, 1950 ... (72)
Andreasson, Ulf, 196 ... (65)
Mattsson, Niklas, 19 ... (63)
Andreasen, Niels (53)
visa fler...
Portelius, Erik, 197 ... (52)
Hampel, Harald (35)
Hansson, Oskar (34)
Rosengren, Lars, 195 ... (31)
Minthon, Lennart, 19 ... (31)
Brinkmalm-Westman, A ... (29)
Brinkmalm, Gunnar, (24)
Minthon, Lennart (23)
Skoog, Ingmar, 1954- ... (19)
Prince, Jonathan A (18)
Bogdanovic, Nenad (17)
Månsson, Jan-Eric, 1 ... (15)
Londos, Elisabet (14)
Gustavsson, Mikael K ... (14)
Vanmechelen, Eugeen (14)
Andreasen, N (13)
Bjerke, Maria, (13)
Edman, Åke, (13)
Gobom, Johan, (13)
Sjögren, Magnus (13)
Olsson, Bob, 1969-, (12)
Gustafson, Deborah, ... (12)
Vanderstichele, Hugo (12)
Hampel, H. (12)
Hagberg, Lars, 1951- ... (11)
Palmer, Mona Seibt (11)
Rüetschi, Ulla, 1962 ... (11)
Rolstad, Sindre, 197 ... (11)
Trojanowski, John Q (11)
Pedersen, Nancy L (10)
Anckarsäter, Henrik, ... (10)
Zetterberg, Madelein ... (10)
Davidsson, Pia, 1962 ... (10)
de Leon, Mony J (10)
Jonsson, Michael, 19 ... (10)
Öhrfelt Olsson, Anni ... (10)
Landgren, Sara, 1980 ... (10)
Höglund, Kina, 1976- ... (10)
Fahlke, Claudia, 196 ... (9)
Johansson, Boo, (9)
Shaw, Leslie M (9)
Lewczuk, Piotr (9)
Johansson, Annica, 1 ... (9)
Buerger, Katharina (9)
visa färre...
Lärosäte
Göteborgs universitet (504)
Lunds universitet (58)
Uppsala universitet (18)
Linköpings universitet (10)
Chalmers tekniska högskola (8)
Stockholms universitet (4)
visa fler...
Högskolan i Jönköping (2)
Linnéuniversitetet (1)
Luleå tekniska universitet (1)
Umeå universitet (1)
visa färre...
Språk
Engelska (486)
Svenska (19)
Ämne (HSV)
Medicin och hälsovetenskap (472)
Naturvetenskap (14)
Samhällsvetenskap (11)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy